XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Beginning at Dec. 31, 2022 $ (446,850)   $ 3 $ 21,430 $ (774) $ (467,509)
Balance at Beginning at Dec. 31, 2022   $ 843,687        
Balance at Beginning (in Shares) at Dec. 31, 2022     32,612      
Balance at Beginning (in Shares) at Dec. 31, 2022   104,417        
Issuance of common stock upon exercise of stock options 602     602    
Issuance of common stock upon exercise of stock options, shares     219      
Repurchase of unvested early exercised stock options     (123)      
Vesting of restricted common stock 1,282     1,282    
Unrealized gain (loss) on marketable securities 476       476  
Stock-based compensation 2,195     2,195    
Net loss (35,625)         (35,625)
Balance at Ending at Mar. 31, 2023 (477,920)   $ 3 25,509 (298) (503,134)
Balance at Ending at Mar. 31, 2023   $ 843,687        
Balance at Ending (in Shares) at Mar. 31, 2023     32,708      
Balance at Ending (in Shares) at Mar. 31, 2023   104,417        
Balance at Beginning at Dec. 31, 2023 469,076   $ 16 1,172,570 (76) (703,434)
Balance at Beginning (in Shares) at Dec. 31, 2023     158,832      
Issuance of common stock upon exercise of stock options 1,845     1,845    
Issuance of common stock upon exercise of stock options, shares     525      
Vesting of restricted common stock 41     41    
Unrealized gain (loss) on marketable securities (72)       (72)  
Stock-based compensation 7,373     7,373    
Net loss (53,721)         (53,721)
Balance at Ending at Mar. 31, 2024 $ 424,542   $ 16 $ 1,181,829 $ (148) $ (757,155)
Balance at Ending (in Shares) at Mar. 31, 2024     159,357